Literature DB >> 12650472

Early echocardiographic predictors of myxomatous mitral valve disease in dachshunds.

L H Olsen1, T Martinussen, H D Pedersen.   

Abstract

Myxomatous mitral valve disease in dogs is heritable, and it is therefore important to detect the early signs of the disease. This study was conducted to assess the predictive value of early echocardiographic and auscultatory signs of mitral valve prolapse, measured in terms of the leaflet thickness, the area of the regurgitant jet, and the intensity of the murmur, on the increases in left ventricular end diastolic diameter (LVEDD) and left atrial diameter (LAD) in a population of 190 clinically healthy dachshunds followed up for three years. The most significant predictor of an increase in LVEDD was the interaction between the index of mitral valve prolapse and the area of the regurgitant jet (P < 0.0001). In dogs with a jet area greater than 50 per cent of the left atrium, the disease progressed more quickly in terms of increases in LVEDD in relation to the severity of the prolapse at the initial examination. In dogs with smaller jets, the initial prolapse index was not significantly associated with increases in LVEDD. The initial index of mitral valve prolapse, the area of the jet and the intensity of the heart murmur were all significant predictors of an increase in LAD.

Entities:  

Mesh:

Year:  2003        PMID: 12650472     DOI: 10.1136/vr.152.10.293

Source DB:  PubMed          Journal:  Vet Rec        ISSN: 0042-4900            Impact factor:   2.695


  11 in total

Review 1.  Differentiating the aging of the mitral valve from human and canine myxomatous degeneration.

Authors:  Patrick S Connell; Richard I Han; K Jane Grande-Allen
Journal:  J Vet Cardiol       Date:  2012-02-24       Impact factor: 1.701

2.  Comparison of electrocardiographic parameters in dogs with different stages of myxomatous mitral valve disease.

Authors:  Yejin Na; Dohee Lee; Taesik Yun; Yoonhoi Koo; Yeon Chae; Hakhyun Kim; Mhan-Pyo Yang; Byeong-Teck Kang
Journal:  Can J Vet Res       Date:  2021-10       Impact factor: 1.310

3.  Clinical severity score system in dogs with degenerative mitral valve disease.

Authors:  J López-Alvarez; J Elliott; D Pfeiffer; Y-M Chang; M Mattin; W Moonarmart; M J Hezzell; A Boswood
Journal:  J Vet Intern Med       Date:  2015 Mar-Apr       Impact factor: 3.333

4.  Prevalence of and risk factors for degenerative mitral valve disease in dogs attending primary-care veterinary practices in England.

Authors:  M J Mattin; A Boswood; D B Church; J López-Alvarez; P D McGreevy; D G O'Neill; P C Thomson; D C Brodbelt
Journal:  J Vet Intern Med       Date:  2015-04-09       Impact factor: 3.333

5.  Degenerative Valvular Disease in the Cavalier King Charles Spaniel: Results of the UK Breed Scheme 1991-2010.

Authors:  S Swift; A Baldin; P Cripps
Journal:  J Vet Intern Med       Date:  2017-01-05       Impact factor: 3.333

6.  A radiographic measurement of left atrial size in dogs.

Authors:  Xavier Sánchez Salguero; David Prandi; Francisco Llabrés-Díaz; Edgar Garcia Manzanilla; Claudio Bussadori
Journal:  Ir Vet J       Date:  2018-12-17       Impact factor: 2.146

7.  A retrospective study of clinical signs and epidemiology of chronic valve disease in a group of 207 Dachshunds in Poland.

Authors:  Magdalena Garncarz; Marta Parzeniecka-Jaworska; Michał Jank; Magdalena Łój
Journal:  Acta Vet Scand       Date:  2013-07-11       Impact factor: 1.695

8.  Breeding Restrictions Decrease the Prevalence of Myxomatous Mitral Valve Disease in Cavalier King Charles Spaniels over an 8- to 10-Year Period.

Authors:  A C Birkegård; M J Reimann; T Martinussen; J Häggström; H D Pedersen; L H Olsen
Journal:  J Vet Intern Med       Date:  2015-11-17       Impact factor: 3.333

9.  Mitral Regurgitation Severity and Left Ventricular Systolic Dimension Predict Survival in Young Cavalier King Charles Spaniels.

Authors:  M J Reimann; J E Møller; J Häggström; T Martinussen; S S C Zatrazemi; L Svanholm; L B M Nielsen; H D Pedersen; L H Olsen
Journal:  J Vet Intern Med       Date:  2017-06-01       Impact factor: 3.333

10.  The chromogranin A-derived peptides catestatin and vasostatin in dogs with myxomatous mitral valve disease.

Authors:  Katja Höglund; Jens Häggström; Odd Viking Höglund; Mats Stridsberg; Anna Tidholm; Ingrid Ljungvall
Journal:  Acta Vet Scand       Date:  2020-08-05       Impact factor: 1.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.